FilingSEC EDGAR8-K
Co-Diagnostics Collaborates with ReadyGo on Blood-Based Diagnostics
· SEC accepted
StageFeasibility Evaluation
Filing content
Co-Diagnostics is collaborating with ReadyGo Diagnostics to evaluate the feasibility of using blood-based sample preparation for its PCR platform, starting with Ebola detection.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…